ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prognosis of radiotherapy in medullary thyroid carcinoma patients without distant metastasis

Huang, Shaojun; Zhong, Jiana; Zhang, Zhen; Chen, Rongping; Li, Jitong; Sun, Jia*; Chen, Hong*南方医科大学
Translational Cancer Research2021-11DOI: 10.21037/tcr-21-1179
1被引7阅读
引用收藏
分享

摘要

Background: Medullary thyroid carcinoma (MTC) is an advanced disease with a poor prognosis. Although radiotherapy is widely utilized to treat MTC, it is still controversial. MTC patients without distant metastases have not been investigated to explore indications for adjuvant radiotherapy. This study aims to investigate the impact of radiotherapy on the survival of MTC patients without distant metastases. Methods: Data of MTC patients without distant metastasis who underwent total thyroidectomy between 2010 and 2015 were obtained from the Surveillance, Epidemiology and End Results (SEER) database. Propensity score matching was performed to analyze the relationship between radiotherapy and cancer-specific survival (CSS). Results: Seventy-four of 718 MTC patients without distant metastases received radiotherapy and underwent total thyroidectomy. A total of 148 patients were screened via propensity score matching analysis. Multivariate Cox regression indicated that factors including age, sex, radiotherapy and chemotherapy were independent predictors of CSS. Based on these factors, MTC patients without distant metastasis were classified into two risk groups using a nomogram and risk classification system. The C-index of the nomogram was 0.791. The calibration curves showed good consistency of CSS between the actual observation and the nomogram prediction, and decision curve analysis (DCA) showed great clinical usefulness of the nomogram. The three-year CSS of the radiotherapy group was 85.3%, and that of the surgery group was 95%. Particularly, compared with the surgery group, the three-year CSS of subgroups of the radiotherapy group, including male patients and those aged >48 years, was decreased. Conclusions: Radiotherapy results in worse CSS for MTC patients without distant metastases. To maximize benefits, decisions about individual radiotherapy should weigh its advantages and disadvantages.

学科与关键词

关键词
Medullary thyroid cancer (MTC)radiotherapyprognosispropensity score matchingThe Surveillance Epidemiology and End Results database (SEER database)
相关
加载中…
  • Peptide Receptor Radionuclide Therapy in Patients With Advanced Progressive Medullary Thyroid Cancer Efficacy, Safety, and Survival Predictors
    Liu, Qingxing; Kulkarni, Harshad R.; Zhao, Tianzhi; Schuchardt, Christiane; Chen, Xiaoyuan; Zhu, Zhaohui*; Zhang, Jingjing*; Baum, Richard P.*CLINICAL NUCLEAR MEDICINE, 2023, 48(3): 221-227.被引 2
  • The Prognostic Value of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma: A Propensity-Matched Study Based on SEER Database
    Zhang, Chi; Wang, Qin; Hu, Liwen; Cong, Zhuangzhuang; Qiang, Yong; Xu, Fei; Zhang, Zheng; Luo, Chao; Qiu, Bingmei; Li, Xiaokun*; Shen, Yi*Cancers, 2022, 14(19): 4938.被引 1
  • Clinical outcomes of a cohort of 271 patients with lung metastases from differentiated thyroid carcinoma
    Maciel, Joana*; Cavaco, Daniela; Silvestre, Catarina; Pereira, Joana Simoes; Vilar, Helena; Leite, ValerianoClinical Endocrinology, 2022, 97(6): 814-821.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Translational Cancer Research
发表日期
2021-11
卷期
第 10 卷, 第 11 期
页码
4714-+
DOI
10.21037/tcr-21-1179
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81770835]; Key-Area Research and Development Program of Guangdong Province [2019B020230001]

作者

  • H

    Huang, Shaojun (第一作者)

    southern med univ

  • Z

    Zhong, Jiana

    southern med univ

查看全部 7 位作者收起作者
  • Z

    Zhang, Zhen

    southern med univ

  • C

    Chen, Rongping

    southern med univ

  • L

    Li, Jitong

    southern med univ

  • S

    Sun, Jia (通讯)

    southern med univ

  • C

    Chen, Hong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417